This post was contributed by a community member. The views expressed here are the author's own.

Community Corner

congrat's REGENERON ON BEING NAMED #1 in the world

 

 

Congratulations to  Regeneron Pharmaceuticals, Inc., one of Greenburgh's major bio tech companies, on being named by SCIENCE Magazine as  the #1 employer in the global biopharmaceutical industry in the journal's annual Top Employers Survey for the second year in a row.  Regeneron currently employs over 1,500 employees at the Landmark in Eastview.  Regeneron is located near another Greenburgh asset: Madison Square Garden's training facility for the NY Knicks, Liberty and Rangers team.  On Monday Regeneron broke ground to build another 300,000 square feet of lab and office space on property across the street from their Greenburgh offices- in Mt Pleasant. Another 400 jobs will be created!  

Find out what's happening in Rivertownswith free, real-time updates from Patch.

 

The campus that currently houses Regeneron and other bio tech companies is becoming the bio tech capital of the Hudson Valley. This morning I was approached by representatives of another bio tech company that is hoping to build another lab at the Greenburgh portion of the Landmark  campus -in 2014.

Find out what's happening in Rivertownswith free, real-time updates from Patch.

 

.

The 2013 Science survey sought to identify the companies with the best reputations as employers, based on 3,656 survey responses from readers of Science and other survey invitees.  Survey participants came from North America (81%), Europe (10%), and Asia/Pacific Rim (7%); over 80% worked in private industry.  Details of the rankings and survey results can be found in sciencecareers.org and will be featured in the October 25, 2013 print issue. 

 

About Regeneron Pharmaceuticals
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis.  For additional information about the company, please visit www.regeneron.com

We’ve removed the ability to reply as we work to make improvements. Learn more here

The views expressed in this post are the author's own. Want to post on Patch?